Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...

Methotrexate (MTX) is a drug that has been used to treat psoriatic arthritis (PsA) for more than 40 years. Alone or in ... Its initial use, dating to the late 1940s, was in high doses to treat ...

Patients were randomised 1:1:1 to either placebo or CZP 200 mg every 2 weeks (Q2W ... and the sustained improvements across most PsA disease domains support the use of CZP for the long-term ...

Researchers conducted a post hoc analysis of the COAST-V trial to compare the effects of ixekizumab with both placebo and an active control, adalimumab ... (Q2W or Q4W), 40 mg adalimumab Q2W ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...

Alvotech and Dr. Reddy’s announce FDA acceptance of Biologic License Application for AVT03, a proposed biosimilar to Prolia® and Xgeva®.

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

The pause of credit card usage comes a week after DOGE discovered nearly $40 billion in spending last year linked to government-issued plastic. The pause of credit card use by federal employees ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...